ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Imnovid 4 mg, Hartkapseln - 14
61249008 Bristol-Myers Squibb SA
Imnovid 4 mg, Hartkapseln02.06.2014
  02.06.2014
Pomalidomide (L04AX06) 
WHO-DDD 
07.16.40.14
07.16.40. 
A  
No 
IPCI
PR  
k.A.PR
  
7680612490081Synthetika
  
Composition
pomalidomidum 4 mg, mannitolum, amylum pregelificatum natrii stearylis fumaras corresp. natrium 0.033 mg, Kapselhülle: gelatina, E 171, E 132, E 133, Drucktinte: lacca, E 171, simeticonum, propylenglycolum, ammoniae solutio 28 per centum, pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Pomalidomidum4 mg
BAG: Active AgentDose
Pomalidomidum4 mg
 
Inactive agentsDoseadditional_information
Ammoniae Solutio28  
Amylum Pregelificatum Natrii Stearylis Fumaras  
E 132 color.
E 133 color.
E 171 color.
Gelatina Kapselhülle
Lacca Drucktinte
Mannitol  
Per Centum  
Pro Capsula  
Propylenglycol  
Simeticone  
 
Source
Data was imported : 07.10.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home